10th Annual Biological Production Forum 2011

Germany

Cevec Pharmaceutials GmbH Details

Cevec Pharmaceutials GmbH

Company Profile:

Cevec offers human cell expression systems for the production of safe and effective therapeutic proteins. Proteins manufactured in our amniocyte derived human cell lines show substantial advantages in post translational modifications compared to other systems. The stable producing CAP and the new transiently producing CAP-T cells meet all regulatory guidelines and are perfectly designed to exceed any competitive expression yields. The CAP technology offers a one stop protein expression solution all the way from small scale research phase up to large scale pharmaceutical production.

Key Products:

CAP cell line for stable protein expression

• Stable and very high yield expression of human proteins
• Authentic human like post translational modifications
• High density growth in suspension under serum free, chemically defined conditions
• Immortalised by a function not oncogenic in human
• Ethically accepted source of origin
• Allows fast and easy cell line development
• Validated stable growth in different types of bioreactos
• Certified Master Cell Bank (MCB)

CAP-T cell line for transient protein expression

• Incorporates ALL advantages of parental CAP cells
• Proceed within two weeks from gene to milligram and gram amounts of protein
• Efficient and scalable transfection using different commercial reagents

Website:
www.cevec-pharmaceuticals.com